Related references
Note: Only part of the references are listed.Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation
Isabel Goncalves et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
The Roles of Neutral Sphingomyelinases in Neurological Pathologies
Charles R. Horres et al.
NEUROCHEMICAL RESEARCH (2012)
Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes
Melissa N. Barber et al.
PLOS ONE (2012)
Markers of Endogenous Desaturase Activity and Risk of Coronary Heart Disease in the CAREMA Cohort Study
Yingchang Lu et al.
PLOS ONE (2012)
Fish Oil Supplementation Alters the Plasma Lipidomic Profile and Increases Long-Chain PUFAs of Phospholipids and Triglycerides in Healthy Subjects
Inger Ottestad et al.
PLOS ONE (2012)
Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy
Chunxiu Hu et al.
MOLECULAR BIOSYSTEMS (2011)
Serum Lipidomics Meets Cardiac Magnetic Resonance Imaging: Profiling of Subjects at Risk of Dilated Cardiomyopathy
Marko Sysi-Aho et al.
PLOS ONE (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
Leon J. A. Spijkers et al.
PLOS ONE (2011)
Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study
Tatjana Stojakovic et al.
ATHEROSCLEROSIS (2010)
Metabolism and atherogenic disease association of lysophosphatidylcholine
Gerd Schmitz et al.
ATHEROSCLEROSIS (2010)
Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
Jose Antonio Chavez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)
Marcus E. Kleber et al.
BMC MEDICAL GENETICS (2010)
Ceramide in Redox Signaling and Cardiovascular Diseases
Xiang Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: Lipidomics analysis of a Diabetes Antibody Standardization Program sample subset
Christina M. Sorensen et al.
CLINICAL BIOCHEMISTRY (2010)
Cross-talk between Remodeling and de Novo Pathways Maintains Phospholipid Balance through Ubiquitination
Phillip L. Butler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Lipidomics reveals a remarkable diversity of lipids in human plasma
Oswald Quehenberger et al.
JOURNAL OF LIPID RESEARCH (2010)
Genetic variation in lipid desaturases and its impact on the development of human disease
Diana M. Merino et al.
LIPIDS IN HEALTH AND DISEASE (2010)
A genome-wide perspective of genetic variation in human metabolism
Thomas Illig et al.
NATURE GENETICS (2010)
Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
V. D. F. de Mello et al.
DIABETOLOGIA (2009)
Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients
Juergen Graessler et al.
PLOS ONE (2009)
Genetic Determinants of Circulating Sphingolipid Concentrations in European Populations
Andrew A. Hicks et al.
PLOS GENETICS (2009)
Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
Christian Gieger et al.
PLOS GENETICS (2008)
Elevated plasma free fatty acids predict sudden cardiac death:: a 6.85-year follow-up of 3315 patients after coronary angiography
Stefan Pilz et al.
EUROPEAN HEART JOURNAL (2007)
Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy
Wenjing Zheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease
Stefan Pilz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
When do lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis
Yael Pewzner-Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope corrections algorithim (vol 1686, pg 108, 2004)
G Liebisch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Identification of a family of animal sphingomyelin synthases
K Huitema et al.
EMBO JOURNAL (2004)
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family
RD Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Palmitate-induced apoptosis can occur through a ceramide-independent pathway
LL Listenberger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function
K Maedler et al.
DIABETES (2001)
Plasma sphingomyelin level as a risk factor for coronary artery disease
XC Jiang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)